Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial.
Lee JW, Griffin M, Kim JS, Lee Lee LW, Piatek C, Nishimura JI, Carrillo Infante C, Jain D, Liu P, Filippov G, Sicre de Fontbrune F, Risitano A, Kulasekararaj AG; ALXN2040-PNH-301 Investigators.
Praxis (Bern 1994). 2016 May 11;105(10):581-6. doi: 10.1024/1661-8157/a002350.
PMID:27167481
Navigating the Complement Pathway to Optimize PNH Treatment with Pegcetacoplan and Other Currently Approved Complement Inhibitors.
Hillmen P, Horneff R, Yeh M, Kolev M, Deschatelets P.
Int J Mol Sci. 2024 Aug 31;25(17):9477. doi: 10.3390/ijms25179477.
PMID:39273426
ATP1A3-Related Disorder.
Brashear A, Sweadner KJ, Haq I, Napoli E, Ozelius L.
2008 Feb 7 [updated 2024 Dec 5]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
PMID:20301294
Abdominal epilepsy.
Zinkin NT, Peppercorn MA.
Best Pract Res Clin Gastroenterol. 2005 Apr;19(2):263-74. doi: 10.1016/j.bpg.2004.10.001.